Prograf
Showing 26 - 50 of 504
GVHD, Hematopoietic/Lymphoid Cancer Trial in Winston-Salem (fludarabine phosphate, busulfan, cyclophosphamide)
Active, not recruiting
- Graft Versus Host Disease
- Hematopoietic/Lymphoid Cancer
- fludarabine phosphate
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Hematologic Malignancies Trial in Chicago, New York (device, drug, radiation)
Recruiting
- Hematologic Malignancies
- CliniMACS® CD34 Reagent System
- +7 more
-
Chicago, Illinois
- +1 more
Sep 20, 2022
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Kidney; Complications, Allograft, Transplantation Infection Trial in Loma Linda (Immunosuppressive Agents)
Active, not recruiting
- Kidney; Complications, Allograft
- Transplantation Infection
- Immunosuppressive Agents
-
Loma Linda, CaliforniaLoma Linda University Medical Center, Transplantation Institute
Apr 28, 2022
Kidney Transplant; Complications Trial in Philadelphia (Extended Release Tacrolimus Tablets, Immediate Release Tacrolimus
Recruiting
- Kidney Transplant; Complications
- Extended Release Tacrolimus Tablets
- Immediate Release Tacrolimus Capsule
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Feb 2, 2022
Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)
Completed
- Renal Transplant
- Arm 1 Everolimus/Reduced dose tacrolimus
-
Toledo, OhioUniversity of Toledo, Health Science Campus
May 2, 2022
GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)
Recruiting
- GVHD
- Hematologic Neoplasms
- Cyclophosphamide
- +3 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Mar 21, 2022
Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate
Not yet recruiting
- Lung Transplant; Complications
- Tacrolimus Extended Release Oral Tablet [Envarsus]
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jun 6, 2022
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant
Recruiting
- Acute GVHD
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Jan 14, 2022
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Epidermolysis Bullosa Trial in Minneapolis (drug, radiation, procedure, biological)
Recruiting
- Epidermolysis Bullosa
- Thymoglobulin
- +8 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center and Medical Center
Jan 20, 2022
Liver Transplantation, Immunosuppression, Neurotoxicity Trial (Tacrolimus, Immediate Release, Oral, Tacrolimus Extended Release
Not yet recruiting
- Liver Transplantation
- +4 more
- Tacrolimus, Immediate Release, Oral
- Tacrolimus Extended Release Oral Tablet
- (no location specified)
Oct 20, 2021
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Post-ERCP Acute Pancreatitis Trial in India, Singapore, United States (Tacrolimus capsule, Placebo, Rectal Indomethacin)
Not yet recruiting
- Post-ERCP Acute Pancreatitis
- Tacrolimus capsule
- +2 more
-
Washington, District of Columbia
- +4 more
May 23, 2022
Myasthenia Gravis Trial in Beijing (Pyridostigmine, Prednisone, Tacrolimus, Pyridostigmine, Tacrolimus)
Recruiting
- Myasthenia Gravis
- Pyridostigmine, Prednisone, Tacrolimus
- Pyridostigmine, Tacrolimus
-
Beijing, Beijing, ChinaYuwei Da
Feb 21, 2021
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,
Completed
- Myelodysplastic Syndrome
- +13 more
- Fludarabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Total-Body Irradiation
- +5 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022
Kidney Transplantation, Renal Transplant Recipients Trial in Atlanta (Lulizumab, Tacrolimus, Thymoglobulin®)
Not yet recruiting
- Kidney Transplantation
- Renal Transplant Recipients
- Lulizumab
- +5 more
-
Atlanta, GeorgiaEmory University Hospital
Sep 22, 2021
Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Warsaw (Tacrolimus, Unbound tacrolimus
Recruiting
- Immunosuppression
- +6 more
- Tacrolimus
- +2 more
-
Warsaw, PolandDepartment of General and Transplant Surgery, Medical University
Apr 14, 2022
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022